Xtalks Announces its Life Science Webinar Calendar for November 2022

Share Article

Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, clinical trials, drug discovery & development, healthcare, laboratory technology, medical device, pharma manufacturing and supply chain, pharmaceutical, pharmaceutical regulation and preclinical.

News Image

Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!

Visit http://www.xtalks.com to see our upcoming webinars:

November 18- Clinically-Relevant Biomarker Strategies in Drug Development and the Potential of Machine-Learning for Biomarker Assessment

November 2- IRT Transformation for Greater Supply Efficiency
November 2- Care is Critical: Lessons Learned from Clinical Trial Inspections
November 3- Decentralization in Action: What Oncology Trials Look Like Now
November 4- How Sponsors are Accelerating Clinical Trials with Automatic EHR Integration
November 8- The Need for Standardization and CDISC: Insights from The University of Alabama, The University of Utah & CDISC
November 9- Driving Outcomes in Medical Affairs — Leveraging Technology to Identify Successful MSL-KOL Relationships
November 10- Deploying a Patient-First Framework to Accelerate Recruitment & Reduce Overall Trial Timelines
November 11- How Site-Based eSource Benefits Sponsors by Boosting Site Success
November 14- How Early Detection & Diagnostic Products Will Shape the Future of Healthcare
November 16- Radiation Toxicity — Considerations for Implementing Radiation Dose Limits in Radiopharmaceutical Trials
November 16- The Changing Face of Trial Recruitment: Site-Only and Recruitment Provider Options
November 16- eConsent — Driving Successful Adoption
November 17- The Importance of Data Integrity and Accessibility in Successful Clinical Trial Management
November 23- The Value of Patient Co-Creation in Clinical Trial Design
November 29- Scaling DCTs to Drive the Transformation of Clinical Development
November 30- Risk Assessment: Traditional and Novel Approaches to Assess and Manage Risks

November 7- Applications of Cryopreserved Human Dissociated Tumor Cells (DTCs) for Drug and Diagnostic Development
November 11- Next-Generation Sequencing Applications for Antiviral Drug Development & FDA Guidance for Data Submission
November 15- Emerging Applications for Liquid Biopsy in Drug Development

November 22- Supporting Antimicrobial Stewardship Using Point of Care CRP Testing
November 25- Using Point of Care Testing to Transform Patient Care in General Practice and Primary Care Networks
November 29- FROM-16: Measuring the Hidden Burden of Family Impact of Disease

November 2- Key Buffer Considerations for AAV Full Capsid Enrichment
November 7- Using Single-Cell DNA Sequencing to Unravel Clonal Heterogeneity & Progression to Richter’s Transformation in CLL
November 9- Detection of COVID-19 Viral RNA in Wastewater as a Simple and Sensitive Method of Outbreak Detection in Large Populations
November 18- Automation of Solid-Phase Aromatic Foldamer Synthesis

November 21- Evaluating Clinical Utility of Medical Devices, Diagnostics & Therapeutics with Conjoint Analysis/Clinical Vignettes

November 11- Meeting the Increasing Manufacturing Demands of the Rapidly Growing Cell and Gene Therapy and Vaccine Markets
November 14- Process Intensification in AAV Gene Therapy
November 29- Constructing a Pharma Development & Manufacturing Project Plan: Steps to Evaluate Risk & Find Efficiencies
November 30- AAV Manufacturing — Overcoming the Challenges of Plasmid DNA

November 3- Quality Control of Vaccines and Other Pharmaceutical Preparations by Total Nitrogen Determination
November 17- Potency Assays for ATMPs — Conception, Development, Validation, Matrixed Approaches and Assay Lifecycle

November 28- Creating a Global CMC Dossier to Achieve Operational Readiness

November 8- How can Humanized Mouse Models be Used to Study Cancer & the Development of New Immune-Targeted Therapies?
November 10- Optimizing Preclinical Drug Development through Immune Receptor Sequencing in Mouse Models


Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://www.xtalks.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ayesha Rashid
+1 (416) 977-6555 x 272
Email >
Visit website